Local Institution - 0172

Kiel, Schleswig-Holstein 24105

2 studies enrolling now · 2 studies all time

What they study most

Non-Small Cell Lung Cancer (NSCLC), Non-small Cell Lung Cancer (NSCLC)

Studies at this site

• A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201) — Recruiting now
• A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202) — Recruiting now